 |
|
New molecular markers for tumor aggressiveness in biliary tract cancer
August 27, 2009Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
The potential role of LN5 and MMP7 in human cancer is receiving increasing attention. However, expression of LN5 and MMP7 in biliary tract cancer has not been clearly addressed. A research article to be published on August 21,2009 in the World Journal of Gastroenterology addresses this question. The research team led by Dr. Hiroyuki Yamamoto of Sapporo Medical University systematically analyzed the expression of LN5 chains and MMP7 in biliary tract cancer.
Using RT-PCR, real-time RT-PCR, immunohistochemistry, casein zymography, and cell invasion assays, the research team analyzed the expression and role of LN5 and MMP7 in biliary tract cancer, in relation to clinicopathological characteristics. Invasive front dominant expression of LNγ2 and LNβ3 was associated with tumor progression. Active MMP7 detected by casein zymography was correlated with depth of invasion and advanced stage. Down-regulation of MMP7 expression by siRNA resulted in a significant decrease in biliary tract cancer cell invasion in vitro.
In the view of Professor Hiroyuki Yamamoto, detection of LNγ2, LNβ3, and active MMP7 could be molecular markers for tumor aggressiveness in biliary tract cancer. Understanding how LNγ2, LNβ3, and active MMP7 are induced and how their expression is blocked may represent a future strategy for therapeutic intervention in the treatment of patients with biliary tract cancer.
Overexpression of LN5 chains, especially LNγ2, and MMP7 has been reported in various types of carcinomas, such as hepatocellular, colorectal, stomach, and esophagus. LN5 chains and MMP7 could be future therapeutic targets in clinical settings.
World Journal of Gastroenterology
In the view of Professor Hiroyuki Yamamoto, detection of LNγ2, LNβ3, and active MMP7 could be molecular markers for tumor aggressiveness in biliary tract cancer. Understanding how LNγ2, LNβ3, and active MMP7 are induced and how their expression is blocked may represent a future strategy for therapeutic intervention in the treatment of patients with biliary tract cancer.
Overexpression of LN5 chains, especially LNγ2, and MMP7 has been reported in various types of carcinomas, such as hepatocellular, colorectal, stomach, and esophagus. LN5 chains and MMP7 could be future therapeutic targets in clinical settings.
World Journal of Gastroenterology
Which is promising as therapeutic targets in patients with biliary tract cancer? EGFR or HER2?
The epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) are involved in the carcinogenesis of many malignancies.
New strategy in tumor treatment
A new strategy proposed by researchers at Dartmouth Medical School and Amtek, Hanover, NH may treat tumors that do not respond to conventional treatment.
More Biliary Tract Cancer Current Events and Biliary Tract Cancer News Articles
 |
Biliary Tract Cancers, An Issue of Surgical Oncology Clinics (The Clinics: Surgery) by Joseph J. Bennett MD FACS (Author) Proposed topics for this issue include: Malignant Masquerade: Dilemmas in Diagnosing Biliary Obstruction; Molecular Mechanisms of Cholangiocarcinogenesis; Multimodality Imaging of Biliary Malignancies; Percutaneous Approach to the Diagnosis and Treatment of Biliary Tract Malignancies; Portal Vein Embolization in Hilar Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma: Current surgical strategy; Management and Extent of Resection for Intrahepatic Cholangiocarcinoma; Surgical Management of Gallbladder Cancer; Transplantation for Cholangiocarcinoma: When and for Whom?; Radical Resection of Biliary Tract Cancers and the Role of Extended Lymphadenectomy; Indications for neoadjuvant, adjuvant and palliative chemotherapy in the treatment of biliary tract cancers. |
 |
2006 ANNUAL MEETING A.H.P.B.A. - DVD 52 AMERICAN HEPATO-PANCREATO-BILIARY ASSOCIATION/2006 PARALLEL: Free paper session - Biliary . Resistin-like molecule alpha reduces gallbladder optimal tension -Dr. John Christein (USA) . Bacteria entombed in the center of cholesterol gallstones induce fewer infectious manifestations than bacteria in the matrix of pigment stones - Dr. Henry Pitt (USA) . The role of CCK-HIDA scan and cholecystectomy in patients with biliary symptoms and normal ultrasound - Dr. Stan Rogers (USA) . Factors influencing recurrence following curative resection in stage II gallbladder carcinoma - Dr. William Jornagin (USA) PARALLEL: Free paper session - Biliary . Biliary tract cancer - disease demographics and current trends in surgical intervention - Dra. Michele Molinari (USA) . Surgical resection for proximal... |
 |
Biliary Tract and Gallbladder Cancer: Diagnosis & Therapy by Charles Thomas (Author), Charles Thomas (Editor), Clifton Fuller (Editor) Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy is a comprehensive and definitive discussion of all aspects of the treatment of malignant tumors of the gallbladder and biliary tract. This is the first book to examine these cancers in such depth, as rapid advances in surgical oncology and radiotherapeutic approaches have demanded the full coverage this text provides. The book progresses logically, with early chapters presenting the epidemiologic, pathologic, and pathogenetic characteristics of BT and GB lesions, followed by excellent discussions of clinical and radiologic diagnosis and staging. Finally, the full arsenal of therapeutic approaches is presented, from the local to systemic, established to experimental. Segments throughout detail the most current cutting-edge... |
|
Carcinoma of the Liver, Biliary Tract and Pancreas (The Management of Malignant Disease series) by J-.C. Gazet (Author) | |
|
Gale Encyclopedia of Medicine: Bile duct cancer by Kevin O. Hwang M.D. (Author) The article is excerpted from Gale Encyclopedia of Medicine. Consult the second edition of this authoritative, comprehensive, in-depth medical guide for information on more than 1,700 medical topics in language accessible to adult laypersons. Presented in a single alphabetical sequence, articles range in length from one or two paragraphs for minor topics, to several pages or more for major topics. Disease/disorder articles typically cover definition; description; causes and symptoms; diagnosis; treatments; prevention; and more. Test/treatment articles typically cover definition; purposes; precautions; preparation; risks; normal and abnormal results; and much more. This second edition includes more than 200 new entries, 300 updated entries, approximately 650 color... | |
 |
Hepatobiliary Cancer (Cancer Treatment and Research) by Paul H. Sugarbaker (Editor) When one deals with cancer, the hepatobiliary malignancies present a challenge to the oncologist that can be best characterized as a series of unsolved clinical and biological dilemmas. Liver metastases from colorectal and other gastrointestinal malignancies, hepatocellular carcinoma, cholangiocarcinoma and gall bladder cancer present an array of problems but have two features in common; these are high morbidity and mortality with an overall poor result from treatment. Even though there are many reasons to be discouraged in the treatment of hepatobiliary cancer, there are some unique features that the liver presents which allow innovative treatment options. First, the liver is one of the few organs in the body that will regenerate over time. Patients who can be made disease... |
|
Advances in the endoscopic management of patients with pancreatic and biliary malignancies.(Review Article): An article from: Southern Medical Journal by William R. Brugge (Author) This digital document is an article from Southern Medical Journal, published by Thomson Gale on December 1, 2006. The length of the article is 5937 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Advances in the endoscopic management of patients with pancreatic and biliary malignancies.(Review Article) Author: William R. Brugge Publication: Southern Medical Journal (Magazine/Journal) Date: December 1, 2006 Publisher: Thomson Gale Volume: 99 Issue: 12 Page: 1358(9) Distributed by Thomson... | |
|
Bile duct cancer: An entry from Thomson Gale's Gale Encyclopedia of Cancer, 2nd ed. by Kevin, M.D. Hwang (Author) Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of Cancer,” a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures. | |
|
Bile Duct Cancer: An entry from Gale's Gale Encyclopedia of Medicine, 3rd ed. by Kevin, M.D. Hwang (Author), Teresa Odle (Author) This digital document is an article from Gale Encyclopedia of Medicine, 3rd ed., brought to you by Gale®, a part of Cengage Learning, a world leader in e-research and educational publishing for libraries, schools and businesses. The length of the article is 1130 words. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. The third edition of this authoritative, comprehensive, in-depth medical guide features information on medical topics in language accessible to adult laypersons. Disease/disorder articles typically cover definition; description; causes and symptoms; diagnosis; treatments; prevention; and more. Test/treatment articles typically cover definition; purposes;... | |
|
Hepatic and Biliary Cancer (Science and Practice of Surgery Series, Vol 8) by Harold J. Wanebo (Editor) |
| © 2009 BrightSurf.com |